Stock Price Quote

ADD-LIFE PHARMA LTD.

NSE : NABSE : 524665ISIN CODE : INE124C01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.460 (0 %)
PREV CLOSE ( ) 0.46
OPEN PRICE ( ) 0.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.50 0.50
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1991
Management Info
- Chairman - Managing Director
Registered Office

Address 412 - 2 / C, Payal Complex, Opp Fortune Towers Sayajigunj,
Vadodara,
Gujarat-390005

Phone

Email --

Website NA

Registrars Details
MAS Services Ltd
AB-4,Safdarjung Enclave,Phase - II,New Delhi
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Jun 06 ANNUAL 06
Net Profit-0.03-0.38
Gross Profit -0.03 -0.38
Operating Profit 0.210.57
Net Sales 3.1311.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Chandra Bhagat Pharm (BSE)
peergroup  120.00 (8.25%)
M.Cap ( in Cr)90.54
Lactose India (BSE)
peergroup  146.00 (4.85%)
M.Cap ( in Cr)184.05
Supriya Lifescience (BSE)
peergroup  353.50 (1.81%)
M.Cap ( in Cr)2773.84
Jenburkt Pharma (BSE)
peergroup  890.00 (0.50%)
M.Cap ( in Cr)383.07
Samrat Pharmachem (BSE)
peergroup  362.40 (1.21%)
M.Cap ( in Cr)113.38

Shareholding Pattern

No Data Found

About Add-Life Pharma Ltd.

Add-Life Pharma Ltd. was incorporated in the year 1991. Its today's share price is 0.46. Its current market capitalisation stands at Rs 6.86 Cr. In the latest quarter, company has reported Gross Sales of Rs. 16.3 Cr and Total Income of Rs.16.3 Cr. The company's management includes .

It is listed on the BSE with a BSE Code of 524665 , NSE with an NSE Symbol of and ISIN of INE124C01016. It's Registered office is at 412 - 2 / C, Payal Complex, Opp Fortune Towers SayajigunjVadodara-390005, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.